Streamlining clinical research templates to make trials faster, less expensive, more efficient
Since 2012, the nonprofit organization TransCelerate Biopharma has worked to develop a template protocol designed to cut costs and shorten timelines for industry-sponsored trials. Separately, the FDA and NIH have also spearheaded an effort to provide a template for all government-funded trials. Several years ago, the two groups began working together, and have now announced that their respective templates have been aligned to further streamline product development in the clinical research industry as a whole.
Movement for real-world evidence as PPD and Evidera launch new research unit
The CRO PPD and the evidence-based solutions company it acquired last year, Evidera, have just launched a new unit to focus on real-world research and market access. The dedicated unit, which will retain the Evidera name, will pair PPD’s medical affairs research operations (MARO) with the evidence-based solutions expertise of Evidera. Jon Williams, who has served as president and CEO of Evidera since it was founded 2013, will lead the new unit.
To read the full articles for this issue of The CenterWatch Weekly, please click here for subscription information